C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings

被引:180
作者
Haas, M. [1 ]
Rahman, M. H.
Racusen, L. C.
Kraus, E. S.
Bagnasco, S. M.
Segev, D. L.
Simpkins, C. E.
Warren, D. S.
King, K. E.
Zachary, A. A.
Montgomery, R. A.
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA
关键词
ABO-incompatible; antibody-mediated rejection; complement; HLA; positive crossmatch; renal biopsy; renal transplantation;
D O I
10.1111/j.1600-6143.2006.01356.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Biopsies of ABO-incompatible and positive crossmatch (HLA-incompatible) renal allografts were retrospectively examined to compare results of C4d and C3d staining, and the correlation between such staining and histologic findings suggestive of antibody-mediated rejection (AMR). A total of 75 biopsies (55 protocol, 17 for graft dysfunction, 3 for other indications) of 24 ABO-incompatible grafts and 244 biopsies (103 protocol, 129 for graft dysfunction, 12 for other indications) of 66 HLA-incompatible grafts were examined; all were stained for C4d and similar to 40% for C3d. In ABO-incompatible grafts, 80% of protocol biopsies and 59% performed for graft dysfunction showed C4d staining in peritubular capillaries (PTC); this staining was not correlated with neutrophil margination in PTC. In HLA-incompatible grafts, PTC C4d was present in 26% of protocol biopsies and 60% of biopsies for graft dysfunction; 92% of biopsies with > 1+ (0-4+ scale), diffuse PTC C4d had >= 1+ margination and/or thrombotic microangiopathy (TMA), compared with 12% of C4d-negative biopsies. C3d was somewhat more predictive of margination than C4d in ABO-incompatible, but not HLA-incompatible, grafts. In summary, while PTC C4d deposition indicates probable AMR in biopsies of HLA-incompatible grafts, including protocol biopsies, there is no histologic evidence that C4d deposition is correlated with injury in most ABO-incompatible grafts.
引用
收藏
页码:1829 / 1840
页数:12
相关论文
共 37 条
[1]  
Alarabi A, 1995, TRANSPLANT P, V27, P3448
[2]   Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection [J].
Baldwin, WM ;
Kasper, EK ;
Zachary, AA ;
Wasowska, BA ;
Rodriguez, ER .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (03) :311-318
[3]  
Böhmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091
[4]  
Böhmig GA, 2001, J AM SOC NEPHROL, V12, P2482, DOI 10.1681/ASN.V12112482
[5]  
CHOPEK MW, 1987, TRANSPLANT P, V19, P4553
[6]  
Collins AB, 1999, J AM SOC NEPHROL, V10, P2208
[7]   Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation [J].
Fidler, ME ;
Gloor, JM ;
Lager, DJ ;
Larson, TS ;
Griffin, MD ;
Textor, SC ;
Schwab, TR ;
Prieto, M ;
Nyberg, SL ;
Ishitani, MB ;
Grande, JP ;
Kay, PA ;
Stegall, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) :101-107
[8]   SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIG) - A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS [J].
GLOTZ, D ;
HAYMANN, JP ;
SANSONETTI, N ;
FRANCOIS, A ;
MENOYOCALONGE, V ;
BARIETY, J ;
DRUET, P .
TRANSPLANTATION, 1993, 56 (02) :335-337
[9]   C4D staining of perioperative renal transplant biopsies [J].
Haas, M ;
Ratner, LE ;
Montgomery, RA .
TRANSPLANTATION, 2002, 74 (05) :711-717
[10]  
Herzenberg AM, 2002, J AM SOC NEPHROL, V13, P234, DOI 10.1681/ASN.V131234